ALEXANDRA JOHNSON: Open Payments
NPI 1780159822 · YULEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 38 payments from 12 companies in 2025. Trend: 2023 $1,113 · 2024 $1,460 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $137 |
| Otsuka America Pharmaceutical, Inc. | 6 | $113 |
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
| Supernus Pharmaceuticals, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Alkermes, Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
Products named: VRAYLAR, ABILIFY ASIMTUFII, AUSTEDO XR, Qelbree, CAPLYTA, COBENFY, ARISTADA, Auvelity.
Industry payments across FL — which companies pay providers there.
